Oramed Pharmaceuticals Inc.
ORMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001176309
In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Oramed Pharmaceuticals Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 89
- −13 vs. Q1 2022
- Shares held
- 6.60M
- −2.44M (−27.0%) vs. Q1 2022
- Total value
- $31.0M
- −$47.3M (−60.4%) vs. Q1 2022
- New holders
- 20
- 24 more added
- Sold out
- 33
- 20 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ORMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 84 | $80.7M |
| Q1 2026 | 64 | $45.0M |
| Q4 2025 | 57 | $37.2M |
| Q3 2025 | 47 | $24.3M |
| Q2 2025 | 47 | $16.3M |
| Q1 2025 | 52 | $16.6M |
| Q4 2024 | 56 | $18.6M |
| Q3 2024 | 55 | $17.0M |
| Q2 2024 | 59 | $15.2M |
| Q1 2024 | 51 | $15.4M |
| Q4 2023 | 56 | $11.9M |
| Q3 2023 | 56 | $5.99M |
| Q2 2023 | 50 | $8.16M |
| Q1 2023 | 61 | $9.29M |
| Q4 2022 | 77 | $43.2M |
| Q3 2022 | 71 | $25.5M |
| Q2 2022 | 89 | $31.0M |
| Q1 2022 | 103 | $78.4M |
| Q4 2021 | 116 | $122.4M |
| Q3 2021 | 93 | $118.9M |
| Q2 2021 | 75 | $51.4M |
| Q1 2021 | 44 | $12.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Oramed Pharmaceuticals Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rhumbline Advisers | 0 | $0 | 0.00% | −34,046−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −21,402−100.0% | Sold out |
| American International Group, Inc. | 0 | $0 | 0.00% | −18,522−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −18,325−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −17,954−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −17,360−100.0% | Sold out |
| Alliancebernstein L.P. | 0 | $0 | 0.00% | −16,700−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −14,777−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −14,370−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −13,744−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −12,752−100.0% | Sold out |
| Voya Investment Management LLC | 0 | $0 | 0.00% | −12,508−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −13,704−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −7,880−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −7,706−100.0% | Sold out |
| Amalgamated Bank | 0 | $0 | 0.00% | −6,457−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −5,400−100.0% | Sold out |
| Ameritas Investment Partners, Inc. | 0 | $0 | 0.00% | −2,094−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,979−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −68−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |